Be part of the knowledge.™

NeuroFrontiers

Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.

So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.

371

LikeLikedUnlike

Episodes 226-240 of 337

PBA Treatment May Reverse Signs of Alzheimer’s Disease
NeuroFrontiers
PBA Treatment May Reverse Signs of Alzheimer’s Disease
- Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
  Peer
- Jini Naidoo, PhD
  Peer
Alzheimer’s Research: Opening the Blood-Brain Barrier with Aducanumab and Focused Ultrasound
NeuroFrontiers
Alzheimer’s Research: Opening the Blood-Brain Barrier with Aducanumab and Focused Ultrasound
- Andrew Wilner, MD, FACP, FAAN
  Peer
- Marc Haut, PhD
  Peer
First Episode Psychosis: Improving Patient Outcomes Through Early Intervention
NeuroFrontiers
First Episode Psychosis: Improving Patient Outcomes Through Early Intervention
- Ashley Baker, MSN, PMHNP
  Peer
- Hannah Brown, MD
  Peer
Investigating the Risk of Schizophrenia Among ADHD Patients with Psychiatric Comorbidities
NeuroFrontiers
Investigating the Risk of Schizophrenia Among ADHD Patients with Psychiatric Comorbidities
Detecting MS Biomarkers: An IgG Antibody Blood Test Offers 90% Accuracy
NeuroFrontiers
Detecting MS Biomarkers: An IgG Antibody Blood Test Offers 90% Accuracy
Investigating the Clinical Utility of the Multiple Sclerosis Disease Activity Test
NeuroFrontiers
Investigating the Clinical Utility of the Multiple Sclerosis Disease Activity Test
- Andrew Wilner, MD, FACP, FAAN
  Peer
- William A. Kilgo, MD
  Peer
advertisement
Adverse Childhood and Lifespan Stressors Take a Toll on MS Disease Severity
NeuroFrontiers
Adverse Childhood and Lifespan Stressors Take a Toll on MS Disease Severity
- Andrew Wilner, MD, FACP, FAAN
  Peer
- Carri Polick, PhD, RN
  Peer
MS in Black and Hispanic Patients: Examining Prevalence and Disease Characteristics
NeuroFrontiers
MS in Black and Hispanic Patients: Examining Prevalence and Disease Characteristics
- Jennifer Caudle, DO
  Peer
- Mitzi Joi Williams, MD
  Peer
Mind Matters: Psychiatric Comorbidity in the Prodromal Phase of MS
NeuroFrontiers
Mind Matters: Psychiatric Comorbidity in the Prodromal Phase of MS
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Anibal Chertcoff, MD
  Peer
Examining Emerging Gut Microbiota Biomarkers for MS
NeuroFrontiers
Examining Emerging Gut Microbiota Biomarkers for MS
MS in Children: Exploring Biomarker Research Advancements
NeuroFrontiers
MS in Children: Exploring Biomarker Research Advancements
- Ahmed Abdelhak, MD
  Peer
New Consensus for Smoldering Disease in MS
NeuroFrontiers
New Consensus for Smoldering Disease in MS
advertisement
Discussing Disparities in MS Care for Underrepresented Populations
NeuroFrontiers
Discussing Disparities in MS Care for Underrepresented Populations
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Tirisham V. Gyang, MD
  Peer
- Gopika Govindan Kutty, MD
  Peer
An Overview of MS Biomarkers
NeuroFrontiers
An Overview of MS Biomarkers
Discussing the Latest in MS Treatment and Disease-Modifying Therapies
NeuroFrontiers
Discussing the Latest in MS Treatment and Disease-Modifying Therapies
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Jay Avasarala, MD, PhD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended